{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Aptevo Therapeutics Stock Plummets to New 52-Week Low of $1.32
Aptevo Therapeutics, Inc. has reached a new 52-week low, reflecting its challenging market position amid significant financial losses. The company shows a negative equity position and a low return on equity, with its stock valued below book value, highlighting ongoing volatility in the biotechnology sector.
Aptevo Therapeutics Hits New 52-Week Low at $1.41
Aptevo Therapeutics, Inc. has reached a new 52-week low, reflecting challenges in the Pharmaceuticals & Biotechnology sector. The company reports significant financial struggles, with a negative return on equity and no dividends. Its market capitalization stands at USD 5 million, indicating a valuation below its book value.
Is Aptevo Therapeutics, Inc. overvalued or undervalued?
As of October 5, 2023, Aptevo Therapeutics, Inc. is considered attractive due to its undervaluation, with a price-to-earnings ratio of 15.2 and a price-to-book ratio of 1.1, making it cheaper than peers like Amgen and Regeneron, while also showing strong stock performance relative to the Sensex.
Is Aptevo Therapeutics, Inc. technically bullish or bearish?
As of October 1, 2023, there is insufficient technical data for Aptevo Therapeutics, Inc. to determine a bullish or bearish outlook.
What does Aptevo Therapeutics, Inc. do?
Aptevo Therapeutics, Inc. is a biotechnology company specializing in oncology and hematology therapeutics, classified as a micro-cap with a market cap of $2.13 million and a recent net profit of -$6 million.
How big is Aptevo Therapeutics, Inc.?
As of Jun 18, Aptevo Therapeutics, Inc. has a market capitalization of $2.13 million, with net sales of $0.00 million and a net profit of -$23.70 million over the latest four quarters. The company reported shareholder's funds of $4.75 million and total assets of $15.59 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
